← Back to Analyst Consensus 
DNTH Buy
Dianthus Therapeutics, Inc. /DE/
Current Price —
Implied Upside —
Analysts 23
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 11, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| Sep 4, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Aug 6, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 5, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Aug 3, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 6, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Apr 9, 2026 | Wolfe Research | initiate | — → Outperform | — | 53% |
| Mar 19, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Mar 12, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 10, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 10, 2026 | Raymond James | upgrade | Outperform → Strong Buy | — | 54% |
| Mar 10, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 10, 2026 | Clear Street | maintain | Buy → Buy | — | 48% |
| Mar 9, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 9, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Mar 9, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 4, 2026 | Guggenheim | maintain | Buy → Buy | $200 | 52% |
| Feb 11, 2026 | Wedbush | maintain | Outperform → Outperform | $55 | 58% |
| Feb 2, 2026 | Jefferies | maintain | Buy → Buy | $81 | 52% |
| Jan 8, 2026 | Truist Securities | maintain | Buy → Buy | $63 | 54% |
| Dec 22, 2025 | Wedbush | reiterate | Outperform → Outperform | $46 | 58% |
| Nov 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Nov 6, 2025 | Wedbush | maintain | Outperform → Outperform | $46 | 58% |
| Oct 14, 2025 | Truist Securities | initiate | — → Buy | $56 | 54% |
| Sep 17, 2025 | Clear Street | initiate | — → Buy | $100 | 48% |
| Sep 12, 2025 | Stifel | maintain | Buy → Buy | $65 | 53% |
| Sep 12, 2025 | Wedbush | maintain | Outperform → Outperform | $44 | 58% |
| Sep 9, 2025 | Raymond James | reiterate | Outperform → Outperform | $63 | 54% |
| Sep 9, 2025 | Guggenheim | maintain | Buy → Buy | $100 | 52% |
| Sep 9, 2025 | Baird | maintain | Outperform → Outperform | $67 | 55% |
| Sep 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Aug 21, 2025 | Wedbush | maintain | Outperform → Outperform | $42 | 58% |
| Jul 2, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| May 13, 2025 | Wedbush | maintain | Outperform → Outperform | $34 | 58% |
| May 13, 2025 | Baird | maintain | Outperform → Outperform | $50 | 55% |
| May 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Mar 12, 2025 | Wedbush | reiterate | Outperform → Outperform | $36 | 58% |
| Mar 12, 2025 | Guggenheim | reiterate | Buy → Buy | $84 | 52% |
| Mar 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Dec 20, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Nov 11, 2024 | Oppenheimer | maintain | Outperform → Outperform | $52 | 52% |
| Nov 8, 2024 | Raymond James | maintain | Outperform → Outperform | $56 | 54% |
| Oct 3, 2024 | Oppenheimer | initiate | — → Outperform | $48 | 52% |
| Sep 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Aug 9, 2024 | Wedbush | maintain | Outperform → Outperform | $36 | 58% |
| Jul 26, 2024 | Baird | initiate | — → Outperform | $58 | 55% |
Price Target Trend
Jul 7, 2026 Latest: $140.8 Oct 24, 2026
EPS Estimates
0y $-3.81
Lo: $-4.10 Hi: $-3.43
11 analysts ▲2
+1q $-1.11
Lo: $-1.36 Hi: $-0.98
10 analysts ▲2
+1y $-4.61
Lo: $-5.77 Hi: $-3.47
11 analysts ▲2
0q $-0.95
Lo: $-1.13 Hi: $-0.39
10 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days